Market Cap 523.81M
Revenue (ttm) 523.85M
Net Income (ttm) 31.40M
EPS (ttm) N/A
PE Ratio 13.58
Forward PE 14.53
Profit Margin 5.99%
Debt to Equity Ratio 0.47
Volume 340,800
Avg Vol 529,830
Day's Range N/A - N/A
Shares Out 46.89M
Stochastic %K 89%
Beta 1.41
Analysts Hold
Price Target $13.67

Company Profile

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analyt...

Industry: Oil & Gas Equipment & Services
Sector: Energy
Phone: 713 328 2673
Address:
6316 Windfern Road, Houston, United States
ZacksResearch
ZacksResearch Aug. 25 at 1:31 PM
$CLB down 28.4% in 6 months β€” time for a turnaround or more turbulence? 🌧️ πŸ” Strategic expansion in the Middle East with new facilities πŸ’ͺ Strong balance sheet with reduced leverage ⚠️ Tariff impact, U.S. market softness, decline in high-margin diagnostic services demand, and dependency on client geological success rates pose risks Mixed outlook for this Zacks Rank #3 (Hold) stock. Full analysis here πŸ‘‰ https://www.zacks.com/stock/news/2741985/core-laboratories-not-a-buy-yet-but-still-worth-holding-on?cid=sm-stocktwits-2-2741985-body-9262&ADID=SYND_STOCKTWITS_TWEET_2_2741985_BODY_9262
0 Β· Reply
ZacksResearch
ZacksResearch Aug. 25 at 12:31 PM
$CLB β€” Hold or Fold? πŸ€” Global expansion, new tech labs, and debt reduction show progress... but tariff pressures, U.S. softness, and volatile demand keep it from being a clear buy. Full breakdown here πŸ‘‰ https://www.zacks.com/stock/news/2741985/core-laboratories-not-a-buy-yet-but-still-worth-holding-on?cid=sm-stocktwits-2-2741985-teaser-9261&ADID=SYND_STOCKTWITS_TWEET_2_2741985_TEASER_9261
0 Β· Reply
macroaxis
macroaxis Aug. 20 at 10:53 AM
$CLB – Bullish Option Volatility Signal: Core Laboratories' Pin Risk Easing – Consider Strategic Opportunities https://www.macroaxis.com/stock-options/CLB/Core-Laboratories-NV?utm_source=dlvr.it&utm_medium=stocktwits
0 Β· Reply
smol_bagholder
smol_bagholder Aug. 6 at 1:06 PM
$CLB Testing all-time highs at $200. Extended but no overhead supply. RSI at 71 suggests stretched but momentum strong.
0 Β· Reply
NVDAMillionaire
NVDAMillionaire Jul. 29 at 4:22 PM
$CLB Outstanding article that hits the mark on CLB's current state. So if you want to refresh your CLB insights or learn about CLB from scratch, this is a must read. https://beyondspx.com/article/core-laboratories-unearthing-value-through-niche-technology-and-financial-discipline-nyse-clb
0 Β· Reply
ZacksResearch
ZacksResearch Jul. 25 at 3:35 PM
$CLB beat earnings β€” but here’s the red flag ⚠️ Q2 topped estimates, but profits still fell year over year as Reservoir Description underdelivered and expenses climbed. Full breakdown here πŸ‘‰ https://www.zacks.com/stock/news/2616841/core-laboratories-q2-earnings-beat-estimates-expenses-increase-yy?cid=sm-stocktwits-2-2616841-teaser-3953&ADID=SYND_STOCKTWITS_TWEET_2_2616841_TEASER_3953
0 Β· Reply
ZacksResearch
ZacksResearch Jul. 25 at 11:57 AM
$CLB Q2 Earnings Beat β€” But Is It Enough to Impress? πŸ€” Core Laboratories posted a slight earnings beat with 19 cents/share, topping estimates by 1 cent πŸ“ˆ. Despite this, the Reservoir Description segment's income decreased compared to the previous year πŸ“‰. Explore the full analysis here πŸ‘‰ https://www.zacks.com/stock/news/2616841/core-laboratories-q2-earnings-beat-estimates-expenses-increase-yy?cid=sm-stocktwits-2-2616841-body-3799&ADID=SYND_STOCKTWITS_TWEET_2_2616841_BODY_3799
0 Β· Reply
Estimize
Estimize Jul. 24 at 5:18 PM
$CLB reported 0.19 EPS and 130.16 revenue for Q2. http://www.estimize.com/intro/clb?chart=historical&metric_name=eps&utm_content=CLB&utm_me
0 Β· Reply
DonCorleone77
DonCorleone77 Jul. 23 at 9:38 PM
$CLB Core Laboratories sees Q3 EPS 18c-22c vs. 25c last year -- Sees Q3 revenue $127.5M/$134.5M, consensus $130.89M.
0 Β· Reply
DonCorleone77
DonCorleone77 Jul. 23 at 9:37 PM
$CLB Core Laboratories reports Q2 EPS ex-items 19c vs. 22c last year -- Q2 revenue $130.2M, consensus $129.19M.
0 Β· Reply
Latest News on CLB
Core Laboratories Inc. (CLB) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 10:51 AM EDT - 4 weeks ago

Core Laboratories Inc. (CLB) Q2 2025 Earnings Call Transcript


CORE LAB REPORTS SECOND QUARTER 2025 RESULTS

Jul 23, 2025, 5:15 PM EDT - 4 weeks ago

CORE LAB REPORTS SECOND QUARTER 2025 RESULTS


Core Laboratories: Better Without Its Non-Core?

Jun 26, 2025, 6:54 AM EDT - 2 months ago

Core Laboratories: Better Without Its Non-Core?


Core Laboratories Inc. (CLB) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 2:14 PM EDT - 4 months ago

Core Laboratories Inc. (CLB) Q1 2025 Earnings Call Transcript


CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

Apr 23, 2025, 5:15 PM EDT - 4 months ago

CORE LAB REPORTS FIRST QUARTER 2025 RESULTS


CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

Jan 29, 2025, 5:15 PM EST - 7 months ago

CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS


Core Laboratories Inc. (CLB) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 12:53 PM EDT - 10 months ago

Core Laboratories Inc. (CLB) Q3 2024 Earnings Call Transcript


CORE LAB REPORTS THIRD QUARTER 2024 RESULTS

Oct 23, 2024, 5:15 PM EDT - 10 months ago

CORE LAB REPORTS THIRD QUARTER 2024 RESULTS


Core Laboratories Inc. (CLB) Q2 2024 Earnings Call Transcript

Jul 25, 2024, 12:21 PM EDT - 1 year ago

Core Laboratories Inc. (CLB) Q2 2024 Earnings Call Transcript


CORE LAB REPORTS SECOND QUARTER 2024 RESULTS

Jul 24, 2024, 5:15 PM EDT - 1 year ago

CORE LAB REPORTS SECOND QUARTER 2024 RESULTS


Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript

Apr 25, 2024, 12:32 PM EDT - 1 year ago

Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript


CORE LAB REPORTS FIRST QUARTER 2024 RESULTS

Apr 24, 2024, 5:15 PM EDT - 1 year ago

CORE LAB REPORTS FIRST QUARTER 2024 RESULTS


CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS

Jan 31, 2024, 5:21 PM EST - 1 year ago

CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS


Core Laboratories Inc. (CLB) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 12:51 PM EDT - 1 year ago

Core Laboratories Inc. (CLB) Q3 2023 Earnings Call Transcript


CORE LAB REPORTS THIRD QUARTER 2023 RESULTS

Nov 1, 2023, 5:15 PM EDT - 1 year ago

CORE LAB REPORTS THIRD QUARTER 2023 RESULTS


CORE LAB REPORTS SECOND QUARTER 2023 RESULTS

Jul 26, 2023, 5:15 PM EDT - 2 years ago

CORE LAB REPORTS SECOND QUARTER 2023 RESULTS


Core Laboratories: Green Shoots, But Too Far Down The Road

May 12, 2023, 7:00 AM EDT - 2 years ago

Core Laboratories: Green Shoots, But Too Far Down The Road


Core Laboratories N.V. (CLB) Q1 2023 Earnings Call Transcript

Apr 27, 2023, 6:38 PM EDT - 2 years ago

Core Laboratories N.V. (CLB) Q1 2023 Earnings Call Transcript


CORE LAB REPORTS FIRST QUARTER 2023 RESULTS:

Apr 26, 2023, 5:15 PM EDT - 2 years ago

CORE LAB REPORTS FIRST QUARTER 2023 RESULTS:


Core Laboratories N.V. (CLB) Q4 2022 Earnings Call Transcript

Feb 2, 2023, 11:40 AM EST - 2 years ago

Core Laboratories N.V. (CLB) Q4 2022 Earnings Call Transcript


Core Laboratories: Likely To Take A Pause, Patience!

Nov 12, 2022, 8:00 AM EST - 3 years ago

Core Laboratories: Likely To Take A Pause, Patience!


Core Laboratories N.V. (CLB) Q3 2022 Earnings Call Transcript

Oct 27, 2022, 5:15 PM EDT - 3 years ago

Core Laboratories N.V. (CLB) Q3 2022 Earnings Call Transcript


ZacksResearch
ZacksResearch Aug. 25 at 1:31 PM
$CLB down 28.4% in 6 months β€” time for a turnaround or more turbulence? 🌧️ πŸ” Strategic expansion in the Middle East with new facilities πŸ’ͺ Strong balance sheet with reduced leverage ⚠️ Tariff impact, U.S. market softness, decline in high-margin diagnostic services demand, and dependency on client geological success rates pose risks Mixed outlook for this Zacks Rank #3 (Hold) stock. Full analysis here πŸ‘‰ https://www.zacks.com/stock/news/2741985/core-laboratories-not-a-buy-yet-but-still-worth-holding-on?cid=sm-stocktwits-2-2741985-body-9262&ADID=SYND_STOCKTWITS_TWEET_2_2741985_BODY_9262
0 Β· Reply
ZacksResearch
ZacksResearch Aug. 25 at 12:31 PM
$CLB β€” Hold or Fold? πŸ€” Global expansion, new tech labs, and debt reduction show progress... but tariff pressures, U.S. softness, and volatile demand keep it from being a clear buy. Full breakdown here πŸ‘‰ https://www.zacks.com/stock/news/2741985/core-laboratories-not-a-buy-yet-but-still-worth-holding-on?cid=sm-stocktwits-2-2741985-teaser-9261&ADID=SYND_STOCKTWITS_TWEET_2_2741985_TEASER_9261
0 Β· Reply
macroaxis
macroaxis Aug. 20 at 10:53 AM
$CLB – Bullish Option Volatility Signal: Core Laboratories' Pin Risk Easing – Consider Strategic Opportunities https://www.macroaxis.com/stock-options/CLB/Core-Laboratories-NV?utm_source=dlvr.it&utm_medium=stocktwits
0 Β· Reply
smol_bagholder
smol_bagholder Aug. 6 at 1:06 PM
$CLB Testing all-time highs at $200. Extended but no overhead supply. RSI at 71 suggests stretched but momentum strong.
0 Β· Reply
NVDAMillionaire
NVDAMillionaire Jul. 29 at 4:22 PM
$CLB Outstanding article that hits the mark on CLB's current state. So if you want to refresh your CLB insights or learn about CLB from scratch, this is a must read. https://beyondspx.com/article/core-laboratories-unearthing-value-through-niche-technology-and-financial-discipline-nyse-clb
0 Β· Reply
ZacksResearch
ZacksResearch Jul. 25 at 3:35 PM
$CLB beat earnings β€” but here’s the red flag ⚠️ Q2 topped estimates, but profits still fell year over year as Reservoir Description underdelivered and expenses climbed. Full breakdown here πŸ‘‰ https://www.zacks.com/stock/news/2616841/core-laboratories-q2-earnings-beat-estimates-expenses-increase-yy?cid=sm-stocktwits-2-2616841-teaser-3953&ADID=SYND_STOCKTWITS_TWEET_2_2616841_TEASER_3953
0 Β· Reply
ZacksResearch
ZacksResearch Jul. 25 at 11:57 AM
$CLB Q2 Earnings Beat β€” But Is It Enough to Impress? πŸ€” Core Laboratories posted a slight earnings beat with 19 cents/share, topping estimates by 1 cent πŸ“ˆ. Despite this, the Reservoir Description segment's income decreased compared to the previous year πŸ“‰. Explore the full analysis here πŸ‘‰ https://www.zacks.com/stock/news/2616841/core-laboratories-q2-earnings-beat-estimates-expenses-increase-yy?cid=sm-stocktwits-2-2616841-body-3799&ADID=SYND_STOCKTWITS_TWEET_2_2616841_BODY_3799
0 Β· Reply
Estimize
Estimize Jul. 24 at 5:18 PM
$CLB reported 0.19 EPS and 130.16 revenue for Q2. http://www.estimize.com/intro/clb?chart=historical&metric_name=eps&utm_content=CLB&utm_me
0 Β· Reply
DonCorleone77
DonCorleone77 Jul. 23 at 9:38 PM
$CLB Core Laboratories sees Q3 EPS 18c-22c vs. 25c last year -- Sees Q3 revenue $127.5M/$134.5M, consensus $130.89M.
0 Β· Reply
DonCorleone77
DonCorleone77 Jul. 23 at 9:37 PM
$CLB Core Laboratories reports Q2 EPS ex-items 19c vs. 22c last year -- Q2 revenue $130.2M, consensus $129.19M.
0 Β· Reply
Estimize
Estimize Jul. 23 at 3:00 PM
$CLB reports after the close, Estimize Consensus +0.01 EPS and +0.75M Revs compared to WS http://www.estimize.com/clb/fq2-2025?utm_content=
0 Β· Reply
ZacksResearch
ZacksResearch Jul. 22 at 3:50 PM
Oil/energy stocks in trouble! $EQNR, $CLB, $OII, $PTEN all face bearish Q2 earnings outlooks. EQNR has a Zacks Rank #3 and 0.00% Earnings ESP. CLB also has a 0.00% Earnings ESP but a Zacks Rank #4 (Sell). OII shows a +4.76% Earnings ESP, but still a Zacks Rank #4. PTEN's Earnings ESP is -2.63% with a Zacks Rank #3. Find out how these companies are positioned amid sector headwinds πŸ‘‰ https://www.zacks.com/stock/news/2603410/watch-these-4-energy-stocks-for-q2-earnings-beat-or-miss?cid=sm-stocktwits-2-2603410-body-3091&ADID=SYND_STOCKTWITS_TWEET_2_2603410_BODY_3091
0 Β· Reply
ZacksResearch
ZacksResearch Jul. 22 at 1:22 PM
4 energy names on earnings watchlist $EQNR, $CLB, $OII and $PTEN all report tomorrow β€” here’s your early read on potential beats or misses for Q2. Get the full earnings preview here πŸ‘‰ https://www.zacks.com/stock/news/2603410/watch-these-4-energy-stocks-for-q2-earnings-beat-or-miss?cid=sm-stocktwits-2-2603410-teaser-2996&ADID=SYND_STOCKTWITS_TWEET_2_2603410_TEASER_2996
0 Β· Reply
ZacksResearch
ZacksResearch Jul. 17 at 12:27 PM
$CLB Q2 preview β€” signs point to a revenue dip πŸ“‰ Second-quarter revenues are likely down year over year, pressured by weakness across key segments. What to watch ahead of earnings πŸ‘‰ https://www.zacks.com/stock/news/2588071/core-laboratories-to-post-q2-earnings-key-metrics-to-watch?cid=sm-stocktwits-2-2588071-teaser-2233&ADID=SYND_STOCKTWITS_TWEET_2_2588071_TEASER_2233
0 Β· Reply
ZacksResearch
ZacksResearch Jul. 17 at 11:11 AM
$CLB headed for a weak Q2 β€” brace for impact! ⚠️ πŸ”» EPS expected to decline by 18.2% YoY πŸ“‰ Reservoir Description & Production Enhancement segments struggling πŸ’Έ Rising costs likely squeezing margins Understand the risks before investing in CLB πŸ‘‰ https://www.zacks.com/stock/news/2588071/core-laboratories-to-post-q2-earnings-key-metrics-to-watch?cid=sm-stocktwits-2-2588071-body-2201&ADID=SYND_STOCKTWITS_TWEET_2_2588071_BODY_2201
0 Β· Reply
JarvisFlow
JarvisFlow Jul. 16 at 2:39 PM
Stifel has updated their rating for Core Laboratories ( $CLB ) to Hold with a price target of 12.
0 Β· Reply
ZacksResearch
ZacksResearch Jun. 30 at 12:19 PM
$CLB down 22% in six months β€” hold or cut losses? ⚠️ Core Lab is battling declining revenues, geopolitical risks, margin pressure, and soft U.S. demand, clouding its growth outlook. Get the full risk breakdown here πŸ‘‰ https://www.zacks.com/stock/news/2557451/core-lab-stock-plunges-22-in-six-months-time-to-hold-or-sell?cid=sm-stocktwits-2-2557451-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2557451_TEASER
0 Β· Reply
ZacksResearch
ZacksResearch Jun. 30 at 11:20 AM
$CLB down 21.6% in six months β€” what’s dragging this oil service stock? πŸ“‰ ⚠️ Declining revenues & earnings with Q1 seeing a 4.4% sequential and 5% YoY revenue drop 🌍 Geopolitical tensions hit Eastern Europe & Middle East operations πŸ“‰ U.S. onshore market weakness adds pressure Final verdict: Zacks Rank #4 (Sell) suggests steering clear for now. https://www.zacks.com/commentary/2557451/core-lab-stock-plunges-22-in-six-months-time-to-hold-or-sell?cid=sm-stocktwits-2-2557451-body-384&ADID=SYND_STOCKTWITS_TWEET_2_2557451_BODY_384
0 Β· Reply
ZacksResearch
ZacksResearch May. 15 at 5:27 PM
$CLB down 29.7% YTD β€” not a buying opportunity but a warning. 🚩 πŸ“‰ Q1 earnings miss with EPS of 8 cents vs. 15-cent estimate πŸ›’οΈ Revenue declines 4.4% sequentially ⚠️ Geopolitical risks and weak capital efficiency Avoid the dip. Full analysis here πŸ‘‰ https://www.zacks.com/commentary/2471740/core-laboratories-down-30-ytd-should-you-hold-or-sell-the-stock?cid=sm-stocktwits-2-2471740-body&ADID=SYND_STOCKTWITS_TWEET_2_2471740_BODY
0 Β· Reply
JarvisFlow
JarvisFlow May. 13 at 7:04 PM
Citigroup has adjusted their stance on Core Laboratories ( $CLB ), setting the rating to Neutral with a target price of 16 β†’ 13.
0 Β· Reply
Estimize
Estimize Apr. 23 at 11:09 PM
$CLB reported 0.14 EPS and 123.59 revenue for Q1. http://www.estimize.com/intro/clb?chart=historical&metric_name=eps&utm_content=CLB&utm_me
0 Β· Reply
DonCorleone77
DonCorleone77 Apr. 23 at 9:43 PM
$CLB Core Laboratories sees Q2 EPS 17c-21c, consensus 19c Sees Q2 revenue $128M-$134M, consensus $128.9M. The company states: "Recent tariffs announced by the U.S., along with OPEC's decision to increase oil production, have resulted in a decline in crude oil prices. The uncertainty of demand for crude oil caused by ongoing trade negotiations, combined with the OPEC+ announcement of increased production quotas, has raised the likelihood that crude oil inventory levels will rise. Core maintains its constructive long-term outlook on international upstream projects for the remainder of 2025 and beyond. The IEA, EIA, and OPEC+ continue to forecast growth in crude oil demand to be between 0.7 and 1.3 million barrels per day for 2025. This demand is mainly driven by non-OECD countries in Asia, India, emerging markets in the Middle East, and Africa. Outside the U.S., large-scale international oil and gas projects are expected to be more resilient to the near-term volatility of crude oil prices. Core sees international project activity to be steady, with committed long-term upstream projects from the South Atlantic Margin, North and West Africa, Norway, the Middle East,and certain areas of Asia Pacific. The Company believes that activity levels associated with smaller-scale, short-cycle crude oil development projects will be more sensitive to a decrease and/or continued volatility of crude oil prices. As such, changes in crude oil prices are anticipated to have a greater impact on drilling and completion activity levels in the U.S. onshore market. Core Lab believes that the proposed tariffs will not apply to the vast majority of service revenue and product sales provided by the Company. Core Lab's services account for over 75% of the Company's total revenue, and are currently not subject to tariffs. Core's product sales have been less than 25% of total revenue, and are primarily manufactured in the U.S.; import tariffs would not apply to approximately 50% of these products, as they are consumed in the U.S. drilling and completion markets. Products manufactured in the U.S. and delivered to international clients may attract tariffs depending on the outcome of international trade negotiations. Certain raw materials imported and used in the Company's U.S manufacturing of products may attract import tariffs applied by the U.S. The Company is currently taking steps to mitigate the impact of potential tariffs."
0 Β· Reply